Abstract

ObjectivesThe aim of this study was to determine the patterns of the accrual clinical symptoms, organ damage, and changes in disease activity in Korean patients with systemic lupus erythematosus (SLE).MethodsThis...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.
Aoibheann Flynn ... Eimear Gilhooley
Clinical rheumatology | VOL. 37
Aoibheann Flynn, et. al.Aoibheann Flynn ... Eimear Gilhooley
01 Feb 2018
SAT0430 Assessment of acr and slicc classification criteria in the asia pacific lupus collaboration cohort
M Harigai ... Y Katsumata
Annals of the Rheumatic Diseases | VOL. 77
M Harigai, et. al.M Harigai ... Y Katsumata
01 Jun 2018
Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus
Lei Zhao ... Jing Dong
Clinical Rheumatology | VOL. 37
Lei Zhao, et. al.Lei Zhao ... Jing Dong
03 Aug 2017
Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus
Deborah M Levy ... Linda T Hiraki
The Journal of Rheumatology | VOL. 46
Deborah M Levy, et. al.Deborah M Levy ... Linda T Hiraki
15 Feb 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers